Meeting
2022 ASCO Annual Meeting
Characterizing malignant transformation in patients with IDH-mutant glioma.
Authors
Vicki Liu
University of California-Los Angeles, Los Angles, CA
Vicki Liu , Blaine S.C. Eldred , Ethan Wetzel , Serendipity Zapanta Rinonos , Negar Khanlou , Linda M. Liau , Phioanh Leia Nghiemphu , Timothy Francis Cloughesy , Benjamin M. Ellingson , Albert Lai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Primary CNS Tumors–Glioma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2065)
DOI
10.1200/JCO.2022.40.16_suppl.2065
Abstract #
2065
Poster Bd #
403
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Prognostic factors in patients with nonmetastatic gastric cancer treated with contemporary multimodality strategies.
First Author: Ariceli Alfaro
Poster
2019 ASCO Annual Meeting
A gene signature of response to radiotherapy in patients with grade II-III oligodendrogliomas.
First Author: Elizabeth Moyal
Poster
2018 ASCO Annual Meeting
Contrast enhancement as a prognostic factor in IDH1/2 mutant glioma.
First Author: Bogdana Suchorska
Poster
2016 Gastrointestinal Cancers Symposium
Impact of preoperative sarcopenia on recurrecnce in gastric cancer surgery.
First Author: Tsutomu Sato